Study Finds No Advantage for High Dose Lipitor
A recent study published in the Journal of the American Medical Association found that high doses of Pfizer's cholesterol lowering drug Lipitor is no better at preventing recurrent heart attacks and heart related death than other drugs. Specifically, the study found that Lipitor at high doses does not prevent heart-related deaths any better than normal doses of Merck's statin drug Zocor.
More information is found here.
Post A Comment / Question